main menu

SurgihoneyRO™ in prestigious International Wound Journal

6th January 2016

Matoke Holdings Ltd (formerly known as Healing Honey International) announces that SurgihoneyTM has been highlighted as a promising new treatment in the International Wound Journal, December 2015 issue.

The article, entitled ‘Reactive Oxygen Species (ROS) and wound healing: the functional role of ROS and emerging ROS-modulating technologies for the augmentation of the healing process,’ highlights the pivotal role of ROS in normal wound healing. It presents a review of the evidence supporting the critical role of ROS in wound healing and infection control at the wound site. The authors conclude: “Accumulating in vitro and in vivo evidence is strongly suggestive of a positive, healing-enhancing role for ROS (mainly in the form of hydrogen peroxide) at the wound site.The role of ROS includes defence against infection and acting as secondary messengers to cells involved in the repair process. The article says new treatments that harness the potential benefits of ROS, such as SurgihoneyTM, are promising provided they remain within non-toxic local concentrations.

Co-author Professor Jonathan Cooke, of the Infectious Diseases and Immunity Section, Division of Infectious Diseases, Department of Medicine, Imperial College London and the Faculty of Biology, Medicine and Health, University of Manchester, said: “Our previous work with Surgihoney has demonstrated its potent antimicrobial activity against pathological micro-organisms, including some that are resistant to most antibiotics.

“Clinical studies with Surgihoney have demonstrated good efficacy in a wide range of wounds and superior activity in preventing and treating infections in patients with IV cannulas undergoing chemotherapy and in women undergoing Caesarean section operations.”

Ian Staples, chief executive of Matoke Holdings Ltd, said: “We are delighted that Surgihoney, a British medical innovation, is featured in such a prestigious international publication. This innovative therapy is now obtainable on prescription in the UK and we look forward to making it available to more patients with infected acute and chronic wounds and burns this year.

To read the open access article online see:http://www.surgihoney.com/pdf/pubmedpapers/16.pdf.Dunnill C, Patton T, Brennan J, et al. Reactive oxygen species (ROS) and wound healing: the functional role of ROS and emerging ROS-modulating technologies for augmentation of the healing process.


« Back to Company Press Releases